SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
S-8

Securities offered to employees pursuant to employee benefit plans

Registration Statements
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe